Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 23, 2026.

Bristol Myers Squibb

What is Bristol Myers Squibb?

Bristol Myers Squibb is a company within the Healthcare category. Bristol Myers Squibb (BMS) is a global biopharmaceutical company engaged in the discovery, development, and delivery of innovative medicines. The company focuses on serious diseases across several therapeutic areas including oncology, cardiovascular, immunology, and fibrotic diseases.

When was Bristol Myers Squibb founded and where is it based?

Bristol Myers Squibb was founded in 1989 (current entity) and is headquartered in Princeton, NJ.

What problems does Bristol Myers Squibb solve for buyers?

Buyers turn to Bristol Myers Squibb for Internal Drug Discovery: Internal R&D departments at large healthcare organizations attempting to synthesize similar compounds or therapies., CRO Partnerships: Contract Research Organizations (CROs) hired to manage clinical trials and development that a company might otherwise partner with BMS for., among 2 documented problem areas.

What questions do buyers ask AI about Bristol Myers Squibb?

Buyers evaluating Bristol Myers Squibb typically ask AI models about "top oncology pharmaceutical companies", "who makes opdivo", "immunotherapy manufacturers", and 4 similar queries.

What does Bristol Myers Squibb offer?

Bristol Myers Squibb's core products are Opdivo, Eliquis, Orencia, Revlimid, Pomalyst, Abecma, Camzyos.

How is Bristol Myers Squibb priced?

Bristol Myers Squibb uses Healthcare Reimbursement / Enterprise/Custom.

Who does Bristol Myers Squibb target?

Bristol Myers Squibb serves Global healthcare providers, hospitals, and patients in oncology, immunology, and cardiovascular care..

What differentiates Bristol Myers Squibb from competitors?

Bristol Myers Squibb BMS maintains one of the world's most advanced oncology and hematology portfolios, specifically leading in immunotherapy and cell therapy.

Official website: https://bms.com/

Last analyzed: August 23, 2026

Problems this brand solves

Buyers search for

About this profile

This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.

If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile